Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Patrick O'brien

COO at Arrowhead Pharmaceuticals, Inc. (ARWR)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.1M

Reported trades

Filed Stock Type Shares Price Value Since
Jan 5SEC ARWRArrowhead Pharmaceuticals, Inc. Sell Plan 4,368520,033 held (−1%) $61.20 $267K +2.5%
Jan 5SEC ARWRArrowhead Pharmaceuticals, Inc. Sell Plan 6,164513,869 held (−1%) $62.23 $384K +0.8%
Jan 5SEC ARWRArrowhead Pharmaceuticals, Inc. Sell Plan 13,451500,418 held (−3%) $62.96 $847K -0.3%
Jan 5SEC ARWRArrowhead Pharmaceuticals, Inc. Sell Plan 11,842488,576 held (−2%) $63.84 $756K -1.7%
Jan 5SEC ARWRArrowhead Pharmaceuticals, Inc. Sell Plan 2,700485,876 held (−1%) $64.44 $174K -2.6%
Jan 5SEC ARWRArrowhead Pharmaceuticals, Inc. Sell Plan 900484,976 held (−0%) $66.01 $59K -4.9%
Jan 5SEC ARWRArrowhead Pharmaceuticals, Inc. Sell Plan 313484,663 held (−0%) $68.00 $21K -7.7%
Jan 5SEC ARWRArrowhead Pharmaceuticals, Inc. Sell Plan 600484,063 held (−0%) $61.12 $37K +2.7%
Jan 5SEC ARWRArrowhead Pharmaceuticals, Inc. Sell Plan 900483,163 held (−0%) $62.25 $56K +0.8%
Jan 5SEC ARWRArrowhead Pharmaceuticals, Inc. Sell Plan 5,873477,290 held (−1%) $62.91 $369K -0.3%
Jan 5SEC ARWRArrowhead Pharmaceuticals, Inc. Sell Plan 2,336474,954 held (−0%) $64.04 $150K -2.0%
Jan 5SEC ARWRArrowhead Pharmaceuticals, Inc. Sell Plan 46474,908 held (−0%) $68.00 $3K -7.7%
  • Sell

    COO Patrick O'brien sold $267K of ARWR at $61.20 — pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Patrick O'brien sold $384K of ARWR at $62.23 — pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Patrick O'brien sold $847K of ARWR at $62.96 — pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Patrick O'brien sold $756K of ARWR at $63.84 — pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Patrick O'brien sold $174K of ARWR at $64.44 — pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Patrick O'brien sold $59K of ARWR at $66.01 — pre-scheduled 10b5-1 plan sale.